BioCentury
ARTICLE | Company News

Appligene Oncor SA, Quantum deal

March 1, 1999 8:00 AM UTC

Quantum acquired 80.2 percent of Appligene Oncor from Oncor Europe S.A.S. (Illkirch, France) for $1.25 million in cash. Appligene provides reagents for use in molecular biology research. Quantum will relocate its Quantum Biotechnology S.A. subsidiary from Montreuil, France, to Strasbourg and integrate it with Appligene. ...